Abstract:Abstract Cutaneous melanoma (CM) is the most aggressive form of skin cancers, and its incidence is increasing annually in Caucasian populations. Previous linkage studies have identified two high-penetrance genes that influence CM risk, including cyclin-dependent kinase inhibitor 2A (CDKN2A) and cyclin-dependent kinase 4 (CDK4). Recent genome-wide association studies (GWASs) on CM have successfully identified several low-penetrance loci on CM susceptibility. However, most GWASs have mainly focused on top significant single nucleotide polymorphisms (SNPs) that could reach the required genome-wide significance level, most of which did not have clear biological functions but were just surrogates for causal variants. To overcome these limitations in GWASs, several complementary approaches have been proposed recently, such as pathway-based analysis and integration analysis of association results with gene expression. These applications have successfully revealed several new cancer susceptibility genes and pathways. Thus, studying SNPs with moderate significance and putative functions in a specific pathway might be helpful to identify SNPs with a relative small effect size and provide additional insight into genetic mechanisms of cancer. Because MAPK pathways play critical roles in development and progression of CM, in this study, we reevaluated the associations between SNPs in 280 MAPK genes and melanoma risk in the discovery GWAS dataset for 1804 CM cases and 1026 cancer-free controls. We found that 34 SNPs with a significance level of 0.001. We further performed in silico prediction using SNPinfo and identified 11 SNPs with putative functions or having a high LD with functional SNPs, five of which were selected to be validated in two other GWAS datasets. A meta-analysis showed that two SNPs (rs1051849 in DUSP14 and rs4608623 near MAFF/PLA2G6) were associated with reduced CM risk (P = 0.0002 for rs1051849 and P = 0.00007 for rs4608623). Further correlation analysis of gene expression levels and SNP genotypes from 90 HapMap CEU cell lines revealed that these two SNPs had significant effects on mRNA expression of DUSP14 and MAFF, respectively (P = 0.025 for rs1051849 and P = 0.010 for rs4608623). We also performed gene-based tests using the hypergeometric method and the Versatile Gene-Based Test for Genome-wide Association (VEGAS) and found that significant SNPs were over-represented in 9 MAPK genes including DUSP14 and MAFF. Our results indicated that genetic variants in DUSP14 and MAFF might be associated with melanoma risk by influencing mRNA expression levels. Further studies are warranted to validate our findings. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr LB-335. doi:1538-7445.AM2012-LB-335

Response To: Polymorphism Within the 3'-Untranslated Region of Denticleless E3 Ubiquitin Protein Ligase Homolog and Survival in Acral Melanoma.

Long Noncoding RNA LUADT1 is Upregulated in Melanoma and May Sponge Mir-28-5p to Upregulate RAP1B.

A Functional Synonymous Variant in PDGFRA is Associated with Better Survival in Acral Melanoma.

Overexpression of Mrna-Decapping Enzyme 1a Predicts Disease- Specific Survival in Malignant Melanoma

Clarifying new molecular subtyping and precise treatment of melanoma based on disulfidptosis-related lncRNA signature

DTL promotes the growth and migration of melanoma cells through the ERK/E2F1/BUB1 axis

Comprehensive Profiling of MDM2/TP53 Genomic Aberration in Chinese Patients with Diverse Malignancies.

Gene Expression Screening Identifies CDCA5 As a Potential Therapeutic Target in Acral Melanoma.

Epigenetic Landscape Analysis of Lncrnas in Acute Myeloid Leukemia with DNMT3A Mutations.

Long Non-Coding RNA Expression Identified by Microarray Analysis: Candidate Biomarkers in Human Acral Lentiginous Melanoma

Genetic Variants in the Genes Encoding Rho Gtpases and Related Regulators Predict Cutaneous Melanoma-Specific Survival

Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.

Polymorphism Of Dna Methyltransferase 3b And Association With Development And Prognosis In Gastric Cancer

Genetic Variants of EML1 and HIST1H4E in Myeloid Cell-Related Pathway Genes Independently Predict Cutaneous Melanoma-Specific Survival

Dna Methyltransferase 3a Rs1550117 Genetic Polymorphism Predicts Poor Survival In Gastric Cancer Patients

Genetic Variants in the PIWI‐piRNA Pathway Gene DCP1A Predict Melanoma Disease‐specific Survival

Abstract 1547: Melanotransferrin ( MELTF , CD228) as a determinant of melanomagenesis: MELTF expression attenuates melanoma progression in the A375-luc2 murine metastasis model and human patients

DTL promotes head and neck squamous cell carcinoma progression by mediating the degradation of ARGLU1 to regulate the Notch signaling pathway

Comprehensive Analysis of the Cuproptosis-Related Gene DLD Across Cancers: A Potential Prognostic and Immunotherapeutic Target.

Rps3 Regulates Melanoma Growth And Sensitivity To Dna Damage And Predicts A Poor Prognosis By Targeting Adt3

Abstract LB-335: Associations of Functional Polymorphisms in Genes Involved in the MAPK Signaling Pathways and Cutaneous Melanoma Risk